Netflix receives an upgrade, while Pinterest is downgraded: Leading analyst recommendations from Wall Street

Today's Key Wall Street Analyst Actions

Stay updated with the most influential analyst recommendations and research notes making waves in the financial markets. Below are the top upgrades, downgrades, and initiations that investors should keep on their radar today, as summarized by The Fly.

Top 5 Analyst Upgrades

• Netflix (NFLX): JPMorgan has raised its rating to Overweight from Neutral, setting a new price target of $120 (previously $124) after resuming coverage. The firm highlights Netflix's robust organic growth, fueled by compelling content, expanding global subscriber base, strong pricing power, and untapped potential in its advertising segment.
• CrowdStrike (CRWD): Piper Sandler upgraded the stock to Overweight from Neutral, maintaining a $520 price target. Despite a 21% decline this year amid AI-related concerns in the cybersecurity sector, the firm believes the recent selloff is excessive.
• Restaurant Brands (QSR): Piper Sandler has moved its rating to Overweight from Neutral and increased the price target to $84 from $71 following the company's Investor Day, citing a strong outlook for future performance. Stifel also upgraded Restaurant Brands to Buy from Hold.
• Twilio (TWLO): TD Cowen upgraded Twilio to Buy from Hold, raising the price target to $160 from $125. The firm sees Twilio as a pivotal player in the growing adoption of AI-powered business-to-consumer interactions.
• Pfizer (PFE): Argus has upgraded Pfizer to Buy from Hold with a $35 price target, citing optimism around the company's expanding GLP-1 pipeline and strong oncology and hematology programs. The firm is increasingly confident in Pfizer's long-term earnings growth prospects beyond 2028.

Top 5 Analyst Downgrades

• Pinterest (PIN): Argus has lowered its rating to Hold from Buy, pointing to challenges in growth as retailers cut back on advertising due to tariffs, while larger rivals like Alphabet (GOOGL) ramp up investments in AI.
• GitLab (GTLB): TD Cowen downgraded GitLab to Hold from Buy, reducing the price target to $29 from $56, citing competitive threats from Anthropic Claude Code and OpenAI Codex.
• Thermon Group (THR): Craig-Hallum cut its rating to Hold from Buy with a $51 price target after Thermon Group's announced $2.2 billion merger with Ceco Environmental (CECO), valuing the deal at 17 times EBITDA.
• Playtika (PLTK): Wedbush downgraded Playtika to Neutral from Outperform, lowering the price target to $3 from $7. The firm notes that SuperPlay earnout obligations are restricting free cash flow, making it difficult for Playtika to reduce leverage ahead of refinancing deadlines in 2027 and 2028.
• AZZ Inc. (AZZ): Wells Fargo has moved AZZ to Equal Weight from Overweight, raising the price target to $132 from $127. The downgrade reflects recent share price gains despite underwhelming 2027 guidance, slower margin growth, and intensifying competition from North American steel producers.

Top 5 Analyst Initiations

• Netflix (NFLX): Barclays has resumed coverage with an Equal Weight rating and a $115 price target. The firm expects short-term valuation support from potential earnings surprises as Netflix steps away from Warner Bros. (WBD) assets, though questions remain about the rationale behind the bidding.
• Beachbody Company (BODI): Craig-Hallum initiated coverage with a Buy rating and a $15 price target, highlighting the company's successful cost restructuring and new growth drivers, including retail launches of Shakeology, P90X, and Insanity, as well as the debut of "10-Minute BODi" targeting inactive Americans.
• Forgent Power Solutions (FPS): Goldman Sachs started coverage with a Buy rating and a $48 price target, noting Forgent's unique ability to supply complete powertrains to data centers. Several other firms, including KeyBanc, JPMorgan, TD Cowen, Oppenheimer, Wolfe Research, and Jefferies, also initiated with Buy-equivalent ratings, while Morgan Stanley and Baird began with Neutral-equivalent ratings.
• Bob's Discount Furniture (BOBS): KeyBanc initiated coverage with an Overweight rating and a $28 price target, representing a 32% potential upside. The company is seen as an attractive small-cap growth opportunity. Other major banks, including JPMorgan, BofA, UBS, RBC Capital, and Morgan Stanley, also started coverage with Buy-equivalent ratings, while Goldman Sachs and Baird initiated with Neutral-equivalent ratings.
• Genmab (GMAB): Wells Fargo began coverage with an Overweight rating and a $40 price target, expressing confidence in the company's upcoming Epkinly and petosemtamab trial results, which are considered largely de-risked based on Phase 2 data.